Treatment of type 1 diabetes
US9271984B2 · kind B2 · utility
4Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2011 |
| Grant date | Mar 1, 2016 |
| Priority date | — |
| Expiry date | Jun 9, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to triazine derivatives of formula (I) for their use in the treatment of type 1 diabetes mellitus, and to compositions comprising said triazine derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.